Waymo and Uber reached a settlement Friday to end their blockbuster trade secrets fight over self-driving car technology, capping off a year of contentious discovery disputes, shocking revelations and numerous delays. Here's a play-by-play of how we got here.
Venable LLP has expanded its growing patent prosecution and counseling practice in San Francisco with the addition of a former Arnold & Porter patent attorney, according to the firm.
Sanofi SA on Tuesday urged the Federal Circuit to stand by its October decision reviving a challenge to Amgen Inc.’s cholesterol medication Repatha, arguing that the panel didn’t stray from the court’s precedent governing how to test when an antibody is patentable.
Judge Rodney Gilstrap in the Eastern District of Texas has long sat atop America’s patent docket. But as the patent litigation landscape shifts, here’s a look at some other judges who should also be on your radar.
The number of patent complaints filed in the Eastern District of Texas dropped significantly following the U.S. Supreme Court’s TC Heartland ruling while Delaware and other venues saw more action, but attorneys say they don’t expect filing trends to change much more going forward.
The resurgence of patent cases at the U.S. International Trade Commission continued in 2017, settling in at a level many believe will become the new standard amid lingering uncertainty for patent owners in district court litigation and an increased awareness of what the commission has to offer.
A new report from legal analytics firm Lex Machina reveals some major shifts in the U.S. patent landscape that came amid a tumultuous year for patent attorneys. Here are some of the key findings from the 2017 data.
A blockbuster Supreme Court ruling. A shift in strategy for patent venues. A downturn in the number of patent suits. 2017 was an unusual year in patent litigation. Here’s a look at the law firms that clients turned to most frequently for help navigating these trends.
The number of petitions for inter partes review filed at the Patent Trial and Appeal Board plunged during the course of 2017, which attorneys say may be the result of several factors, including a decline in patent litigation and fewer PTAB decisions invalidating patents.
Former Uber CEO Travis Kalanick took the stand Tuesday in a California federal jury trial over allegations his company stole self-driving car trade secrets from Alphabet unit Waymo, testifying that leadership in driverless car technology is an “existential” challenge for the ride-hailing company he co-founded.
New U.S. Patent and Trademark Office Director Andrei Iancu will have a lot on his plate as he takes the reins at the agency, from addressing concerns about the fairness of Patent Trial and Appeal Board reviews to safeguarding the patent office’s budget. Here’s what attorneys say should be on his agenda.
The Federal Circuit on Tuesday affirmed a district court’s finding that Hospira doesn’t infringe two blood thinner patents belonging to The Medicines Co., but remanded the question of whether The Medicines Co.'s distribution agreement with another company would render the patents invalid under the so-called on-sale bar.
Microsoft Corp. “is built on IP” that must be enforced even when its patents are infringed by smaller companies like Corel Corp., an attorney for the tech giant said Tuesday during opening statements in its California federal trial, while Corel countered it would pay but only a “fair price.”
A settlement last month that pushed the 1960s protest song “We Shall Overcome” into the public domain was the latest victory for a small group of lawyers who are quietly becoming the go-to team for invalidating questionable copyrights.
Beyoncé and the estate of a YouTube star who’d accused her of stealing audio for her “Formation” music video have agreed to end their copyright fight six months after the court refused to find the video a protected fair use, according to a Monday order in Louisiana federal court.
Boehringer Ingelheim and Teva Pharmaceutical urged a Connecticut federal judge Monday to ignore objections raised by Humana to a $54 million settlement reached with a proposed class of indirect Aggrenox buyers over allegations the drug companies blocked generic alternatives to the stroke-prevention medication from hitting the market.
The Federal Circuit said Tuesday that Actelion Pharmaceuticals Ltd. was not entitled to a patent term adjustment that would have added several days to the life of a patent beyond an adjustment the U.S. Patent and Trademark Office granted, upholding a lower court’s decision.
A patent on motion tracking technology used in various types of military installations has survived the latest challenge over its validity, as the Federal Circuit determined on Tuesday that a combination of prior art did not make its asserted claims obvious.
A California federal judge on Monday ended a $42.3 million copyright infringement suit, which both parties settled, that accused “The Steve Harvey Show” of using unlicensed copies of a music company’s recordings in the television show’s second season.
Husch Blackwell LLP said Monday it has bolstered its international trade group with the addition of a former Adduci Mastriani & Schaumberg LLP attorney who has extensive experience handling Section 337 matters before the U.S. International Trade Commission.
The Patent Trial and Appeal Board on Monday denied Yahoo Inc.’s request for a second chance at convincing the board that two AlmondNet Inc. patents related to targeted advertising were ineligible under Alice, finding that it made no mistakes in assessing either what the patents directed toward or Yahoo's cited authority.
A Supreme Court ruling redrew the patent litigation map. The International Trade Commission became an ever more popular patent venue. District courts saw fewer cases. The Patent Trial and Appeal Board isn’t what it used to be. 2017 was a challenging year for patent attorneys.
While each new year is expected to bring fresh challenges to the legal industry, 2018 will be particularly disruptive to the status quo. Both law firms and organizations that cater to the legal community should prepare for developments like increasing pressure from international clients and data security risks caused by multigenerational gaps, says Jeff Ton of Bluelock LLC.
Over the last year, there were some interesting cases in the indirect purchaser class action arena, with district courts addressing pleading motions, class certification in “pay-for-delay” drug cases, and class certification of nationwide and multistate class claims based on California’s state antitrust law, say Chris Micheletti and Christina Tabacco of Zelle LLP.
At the U.S. Patent and Trademark Office, a set of new fees will go into effect next week. We believe the substantial fee increases for inter partes review proceedings work in favor of foreign applicants, such as Chinese applicants, who are interested in seeking patents in the U.S., say Junqi Hang and Jing Xu of Dragon Intellectual Property Law Firm.
The Federal Circuit does not explain how it calculates its case statistics, and the high level at which the court presents the data obscures the juicy details. So about a year ago I began tracking the disposition of every Federal Circuit decision involving patent law — more than 450 cases in calendar year 2017, says Dan Bagatell of Perkins Coie LLP.
A Wisconsin federal court's recent holding in Manitowoc v. Sany provides further incentive for complainants to use Section 337 to adjudicate trade secret misappropriation claims in the future. But there are limitations, say Alex Lasher and Jared Newton of Quinn Emanuel Urquhart & Sullivan LLP.
Recent cases provide valuable guidance on the application of inter partes review estoppel, and the news is heartening for IPR petitioners. But the divergent approaches taken by the Patent Trial and Appeal Board and the district courts have continued to muddle the issue, say Arpita Bhattacharyya and Barbara McCurdy of Finnegan Henderson Farabow Garrett & Dunner LLP.
Jay Greenberg and Max Volsky, co-founders of litigation finance platform LexShares Inc., analyze emerging trends based on conversations with their investors and executives in this rapidly evolving sector.
As we all look to improve in the new year, there are seven best practices that everyone with a patent and trademark portfolio should put on their to-do list, say attorneys with Eversheds Sutherland LLP.
Study of the Enneagram personality typing system can provide attorneys with better insights into themselves, and into those they interact with professionally, including clients, opposing counsel and judges, says Jennifer Gibbs of Zelle LLP.
The Patent Trial and Appeal Board recently confirmed that while Eleventh Amendment immunity does apply to sovereign actors, those actors waive immunity when filing patent infringement lawsuits. Given that 80 percent of inter partes reviews involve patents in parallel litigation, this order markedly blunts sovereign immunity strategies, says Desmond O'Sullivan of Morrison & Foerster LLP.